News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Wednesday, June 14, 2017 MENLO PARK, Calif., June 14, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Pacific Biosciences also intends to grant the underwriters a 30-day option to purchase up to an additional... Read more
News Release June 14, 2017 Your Contact: Karen Tiano +1 978-495-0093 MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Similar patents pending in other countries; anticipate favorable outcomes Billerica, Massachusetts, June 14, 2017 — MilliporeSigma today announced... Read more
OMAHA, Neb. (June 13, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that the European Patent Office (EPO) has confirmed its intention to grant a patent covering multiplexed ICE COLD-PCR (MX-ICP) technology in the European Union (EU). This Dana-Farber Cancer Institute patent is exclusively licensed to Transgenomic. Paul Kinnon, President and CEO of Transgenomic, commented,... Read more
NEW YORK and HILDEN, Germany, (June 3, 2017) – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as predictive or prognostic tools for use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in... Read more
Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland, June 3, 2017 – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play... Read more
Improves accuracy, decreases steps in a microbiomic workflow NEWS PROVIDED BY Zymo Research Corp. 02 Jun, 2017, 11:05 ET SHARE THIS ARTICLE NEW ORLEANS, June 2, 2017 /PRNewswire/ — Zymo Research Corp. will introduce the newest in its line of kits for microbiomic research. The AccuBIOME™ Amplicon Sequencing Kit utilizes real-time PCR instead of regular PCR... Read more
New Ultra II technology addresses lower input amounts and challenging sample types for Illumina® next generation sequencing systems IPSWICH, Mass., May 30, 2017 /PRNewswire/ — New England Biolabs (NEB®) today announced the expansion of their NEBNext Ultra II NGS library preparation product portfolio to include kits for RNA. The strand-specific NEBNext Ultra II Directional RNA Library... Read more
San Carlos, California , May 30, 2017 NuGEN Technologies today announced that the United States Patent and Trademark Office has issued US Patent No. US 9,650,628 describing the Single Primer Target Enrichment Technology (SPET) which enables targeted nucleic acid analysis by next generation sequencing (NGS). NuGEN offers commercial solutions using SPET to create target and strand-specific libraries... Read more
Combined Offering Provides a Comprehensive Integrated Solution For (NGS) Data Analysis And Interpretation in Healthcare And Research Finland and The Netherlands – May 29, 2017 – Today, Bluebee, a leading provider of high-performance genomics analysis and storage solutions and MediSapiens, a leading biomedical big data curation, management and interpretation company, announce a strategic partnership to provide... Read more
Clinical researchers studying germline disorders now have access to an extension of the highly referenced, Ion AmpliSeq next-generation sequencing (NGS) line of assays. The new Ion AmpliSeq On-Demand targeted sequencing panels for inherited disease research provide easy and practical design customization capabilities to lower upfront costs regardless of project size. Thermo Fisher Scientific will introduce... Read more